Sientra (SIEN) Given a $23.00 Price Target at Craig Hallum

Craig Hallum set a $23.00 price objective on Sientra (NASDAQ:SIEN) in a report published on Monday, TipRanks reports. The brokerage currently has a buy rating on the medical instruments supplier’s stock.

A number of other research firms also recently weighed in on SIEN. BidaskClub raised shares of Sientra from a strong sell rating to a sell rating in a research note on Monday, January 7th. ValuEngine cut shares of Sientra from a strong-buy rating to a buy rating in a report on Thursday, January 24th. William Blair cut shares of Sientra from an outperform rating to a market perform rating in a report on Wednesday, March 13th. Maxim Group reiterated a buy rating and issued a $20.00 price target on shares of Sientra in a report on Monday, February 11th. Finally, Leerink Swann reduced their price target on shares of Sientra from $22.00 to $18.00 in a report on Wednesday, March 13th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and seven have issued a buy rating to the company. Sientra currently has a consensus rating of Buy and an average target price of $20.44.

Shares of SIEN traded up $0.28 on Monday, reaching $8.48. 792,473 shares of the company’s stock were exchanged, compared to its average volume of 767,916. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.12 and a quick ratio of 1.75. The company has a market cap of $220.24 million, a price-to-earnings ratio of -2.61 and a beta of -0.08. Sientra has a 12 month low of $7.10 and a 12 month high of $26.79.

Sientra (NASDAQ:SIEN) last posted its quarterly earnings results on Tuesday, March 12th. The medical instruments supplier reported ($0.86) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.67) by ($0.19). The business had revenue of $19.02 million for the quarter, compared to the consensus estimate of $18.87 million. Sientra had a negative return on equity of 123.51% and a negative net margin of 121.28%. As a group, analysts expect that Sientra will post -2.84 EPS for the current year.

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Alliancebernstein L.P. raised its position in shares of Sientra by 18.8% in the third quarter. Alliancebernstein L.P. now owns 21,500 shares of the medical instruments supplier’s stock valued at $513,000 after purchasing an additional 3,400 shares during the period. Bank of New York Mellon Corp lifted its holdings in shares of Sientra by 1.2% in the 3rd quarter. Bank of New York Mellon Corp now owns 221,093 shares of the medical instruments supplier’s stock worth $5,280,000 after buying an additional 2,726 shares during the period. BlackRock Inc. lifted its holdings in shares of Sientra by 5.5% in the 3rd quarter. BlackRock Inc. now owns 1,572,899 shares of the medical instruments supplier’s stock worth $37,561,000 after buying an additional 82,312 shares during the period. JPMorgan Chase & Co. lifted its holdings in shares of Sientra by 6.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 163,888 shares of the medical instruments supplier’s stock worth $3,913,000 after buying an additional 9,245 shares during the period. Finally, MetLife Investment Advisors LLC lifted its holdings in shares of Sientra by 55.2% in the 3rd quarter. MetLife Investment Advisors LLC now owns 17,996 shares of the medical instruments supplier’s stock worth $430,000 after buying an additional 6,397 shares during the period. Institutional investors and hedge funds own 90.81% of the company’s stock.

About Sientra

Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.

Featured Story: What are municipal bonds?

Analyst Recommendations for Sientra (NASDAQ:SIEN)

Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit